PACIFIC EDGE LIMITED - NZX
PACIFIC EDGE LIMITED - NZX
PACIFIC EDGE LIMITED - NZX
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>PACIFIC</strong> <strong>EDGE</strong> <strong>LIMITED</strong><br />
Notice of Annual Shareholders’ Meeting<br />
Notice is hereby given that the 2011 annual meeting of shareholders of Pacific Edge Limited (the<br />
"Company") will be held at the Ground Floor, Seminar Room, Centre for Innovation, 87 St David<br />
Street, Dunedin on Thursday 25 August 2011, commencing at 4.00 pm.<br />
Ordinary Business<br />
1. Presentation of the annual report for the year ended 31 March 2011, and the report of the<br />
auditor.<br />
2. To consider, and if thought fit, pass the following Ordinary Resolutions:<br />
(a)<br />
(b)<br />
That Anthony Reeve be re-elected as a Director of the Company.<br />
That Christopher Swann be re-elected as a Director of the Company.<br />
(See Explanatory notes)<br />
3. That the re-appointment of PriceWaterhouseCoopers be recorded and to consider, and if<br />
thought fit, pass the following Ordinary Resolution:<br />
(a)<br />
That the Directors of the Company be authorised to fix the auditor's remuneration for<br />
the ensuing year.<br />
4. The Company’s executives will present a summary of the Company’s recent developments and<br />
achievements.<br />
5. To consider, and if thought fit, to pass the following Ordinary Resolution:<br />
(a)<br />
That the shareholders ratify the following recent issues totalling 9,264,742 ordinary<br />
shares in the Company issued pursuant to NZSX Listing Rule 7.3.5 on the following<br />
dates and at the following consideration per share to habitual investors and/or close<br />
business associates of the Company as listed in the Explanatory Notes to the notice of<br />
meeting.<br />
The relevant Share issues are summarised as:<br />
Date Number of Shares Price per Share<br />
27 September 2010 7,993,302 0.2325<br />
27 October 2010 1,271,440 0.2325<br />
TOTAL 9,264,742<br />
Details of the number of shares and names of the individuals' shares to whom shares were<br />
issued are set out in the Explanatory Notes.<br />
Each of the persons to whom the above shares were issued and their associates are excluded<br />
from voting on this resolution pursuant to NZSX Listing Rule 9.3.1.<br />
(see Explanatory Notes)
6. To consider, and if thought fit, to pass the following Ordinary Resolution pertaining to the<br />
maximum level of Directors remuneration for the next financial year:<br />
(a)<br />
That pursuant to clause 25 of the Company’s Constitution and NZSX Listing Rule<br />
3.5.1 the maximum aggregate amount per annum payable by the Company to<br />
Directors in their capacity as Directors remains at $120,000.<br />
The Directors and their associates are excluded from voting on this resolution pursuant to NZSX<br />
Listing Rule 9.3.1.<br />
(See Explanatory Notes)<br />
Important Information<br />
Record Date<br />
Any person who is registered as a shareholder of the Company at 4.00pm on Tuesday 23 August<br />
2011 is entitled to attend and vote at the meeting or to appoint a proxy to attend and vote in their<br />
place.<br />
Proxies<br />
All shareholders are entitled to attend and vote at the meeting or to appoint a proxy to attend and<br />
vote in their place.<br />
Enclosed with this notice of meeting is a proxy form. For the appointment of a proxy to be valid, the<br />
form must be received by Link Market Services either by post (PO Box 91976, Victoria Street West,<br />
Auckland 1142 or Level 16, 19 Victoria Street West, Auckland ) or facsimile (09 375 5990) for email<br />
to: Lmsenquiries@linkmarketservices.com (please quote “Pacific Edge Proxy Form” as the<br />
reference) no later than 48 hours before the start of the meeting (that is by 4.00 pm on Tuesday<br />
23 August 2011). The Chairman, the Directors and Chief Executive Officer offer themselves as<br />
proxy to shareholders and if given discretion will vote in favour of the resolutions.<br />
Any shareholder of the Company entitled to attend and vote at the meeting may appoint another<br />
person or persons as proxy to attend, and vote on his or her behalf. A proxy need not be a<br />
shareholder of the Company. If the proxy form is returned without direction as to how the proxy shall<br />
vote on the resolution then the proxy may vote as he or she thinks fit on that resolution.<br />
All joint holders of a share must sign the proxy form.<br />
Companies may sign under the hand of a duly authorised officer or by power of attorney. If the proxy<br />
form has been signed under a power of attorney, a copy of the power of attorney (unless already<br />
deposited with the Company) and a signed certificate of non-revocation of the power of attorney<br />
must be delivered to the Company with the proxy form.<br />
Corporate Representatives<br />
A corporation that is a shareholder may appoint a representative to attend the meeting on its behalf<br />
in the same manner as that which it could appoint a proxy. Corporate representatives should bring<br />
along to the meeting evidence of their authority to act for the relevant corporation.<br />
Powers of attorney<br />
Any person representing a shareholder(s) by virtue of a power of attorney must bring evidence of<br />
their authority to vote on behalf of the shareholder(s) and power of attorney.
Postal Voting<br />
A shareholder is entitled to exercise his/her right to vote at the meeting by casting a postal vote. A<br />
postal voting form is incorporated in the proxy form attached.<br />
The share registrar, Link Market Services has been authorised by the Board of Directors to receive<br />
and count postal votes at the meeting.<br />
In order for a postal vote to be effective, the proxy/postal voting form must be completed and<br />
returned to the share registrar so that it is received no later than 48 hours before the meeting (that is<br />
by 4.00pm Tuesday 23 August 2011).<br />
PLEASE RETURN YOUR COMPLETED PROXY FORM TO LINK MARKET SERVICES <strong>LIMITED</strong>,<br />
IN ONE OF THE FOLLOWING WAYS BY NO LATER THAN 4.00PM ON TUESDAY 23 AUGUST<br />
2011:<br />
Mail:<br />
New Zealand:<br />
If mailing Proxy Form from within New Zealand, please use the reply-paid envelope<br />
provided.<br />
Outside New Zealand:<br />
You may use the return envelope but affix a stamp for the required postage.<br />
Deliver:<br />
Deliver your completed form to Link Market Services Limited, Level 16, Brookfields<br />
House, 19 Victoria Street West, Auckland<br />
Fax: Fax your completed form to +64 9 375 5990<br />
Scan and<br />
email:<br />
Email to Lmsenquiries@linkmarketservices.com (please put the words “Pacific Edge<br />
Proxy Form” in the subject line for easy identification)<br />
By Order of the Board of Directors<br />
Chris Swann<br />
Chairman<br />
3 August 2011
Explanatory Notes<br />
Resolutions<br />
Business items 2, 3, 5 and 6 are Ordinary Resolutions which require approval by a simple majority<br />
(greater than 50%) of the votes of those shareholders entitled to vote and voting on the question.<br />
Each of the resolutions in item 2 (appointment of Directors) must be voted on individually.<br />
Director re-appointments (Item 2)<br />
In accordance with clause 22.6 of the Company's constitution two Directors being Christopher Swann<br />
and Anthony Reeve, being the longest in office retire by rotation. Both offer themselves for<br />
re-election. The Company has received no other nominations for Directors.<br />
Christopher Swann<br />
Chris Swann was the principal of T D Scott & Co. Limited, a Dunedin-based accountancy and<br />
consulting firm for 10 years. Chris is an experienced business advisor in a number of industries<br />
including the manufacturing, publishing, health, and biotechnology sectors. Chris is manager of the<br />
New Zealand Seed Fund with four investments in biotechnology companies including Pacific Edge.<br />
He also holds other directorships and is a Member of the NZ Institute of Directors.<br />
The Board considers that Mr Swann will not qualify as an Independent Director for the purposes of<br />
the NZSX Listing Rules.<br />
Anthony Reeve<br />
Professor Anthony Reeve is head of the Cancer Genetic Laboratory at the University of Otago. He<br />
was Chairman of the founding Board of Pacific Edge Technology and Chairman of the Scientific<br />
Advisory Board. He is widely viewed as one of the leading cancer geneticists in the world. He has<br />
been a leader in the study of the genetics of embryonal tumours and his laboratory continues to<br />
make significant contributions to research into the genetic basis of multiple cancers. He is a Fellow of<br />
the Royal Society of New Zealand and was recently made an Officer of the New Zealand Order of<br />
Merit. He received this honour for his groundbreaking work in cancer genetics at the University of<br />
Otago.<br />
The Board considers that Mr Reeve will not qualify as an Independent Director for the purposes of<br />
the NZSX Listing Rules.<br />
Share Issue (Item 5)<br />
The issues of a total of 9,264,742 ordinary shares have been completed over the last year pursuant<br />
to NZSX Listing Rule 7.3.5, which in effect allows the Company to issue shares up to an amount<br />
equal to 20% of the total shares on issue in the Company without prior shareholder approval (this is<br />
also known as the "20% Rule"). The Board now seeks retrospective approval of these issues from<br />
shareholders so that the issues will not be counted within the 20% Rule enabling the Board to make<br />
further issues under the 20% Rule in future, if appropriate.<br />
For the purposes of NZSX Listing Rule 6.2.1:<br />
(a)<br />
(b)<br />
The number of shares issued was a total of 9,264,742 ordinary shares;<br />
The purpose of the issues of shares was to provide further working capital for the Company<br />
without incurring the additional expense of a public issue of shares.
(c)<br />
(d)<br />
(e)<br />
(f)<br />
(g)<br />
The issue price for the shares is set out in the table on page 1 of this notice of meeting.<br />
The issue price in each case was paid in cash immediately upon issue of the shares.<br />
The parties to whom the shares were issued are set out in the table below. None of these<br />
parties are Directors or Associated Persons of Directors.<br />
The consideration for the issues was paid in cash upon issue of the shares and the purpose<br />
of the issues was to provide working capital for the Company.<br />
The issues were made at the dates specified in the table below.<br />
The shares issued are ordinary shares that rank equally with all other ordinary shares of the<br />
Company.<br />
Each of the persons to whom shares were issued as shown in the table below (and their respective<br />
associates) are excluded from voting on this resolution pursuant to NZSX Listing Rule 9.3.1 but may<br />
still act as a proxy or voting representative of another person that is not disqualified from voting<br />
under that Listing Rule under Listing Rule 9.3.3 in respect of the shares held by that other person in<br />
accordance with their express instructions.<br />
Persons to Whom Shares Were Issued<br />
Date Shareholder $ Amount Total number of<br />
shares<br />
27 October 2010 Accident Compensation Corporation $255,750.00 1,100,000<br />
Phillip English $10,690.38 45,980<br />
Lord Norrie $4,276.94 18,395<br />
Mrs Jane Shakespeare $4,149.39 17,847<br />
Mr John Shakespeare $4,149.39 17,847<br />
Mr Roger and Mrs Merrill Flood $6,222.10 26,762<br />
Mrs Elizabeth Cadwalader $4,149.39 17,847<br />
Mrs Anne Ballard $6,222.10 26,762<br />
TOTAL $295,610 1,271,440<br />
27 September 2010 K One W One Limited $367,991 1,582,757<br />
Kerry Grant & Michael Owen Tinkler $46,500 200,000<br />
John Hoffeins & Bruce Hoffeins $37,200 160,000<br />
Masfen Securities Limited $321,096 1,381,058<br />
TEA Custodians Limited – Huljich Kiwisaver $250,000 1,075,269<br />
Papageno Trust – Robert Blair Johnston, $4,999 21,500<br />
Stella Nancy McDonald, Peter Donald<br />
Mence<br />
Helistar Trading Trust Limited $13,950 60,000<br />
Ballynagarrick Investment Limited $46,500 200,000<br />
Superlife Trustee Limited $499,875 2,150,000<br />
Superlife Trustee Limited $155,409 668,426<br />
Superlife Investments Limited $33,548 144,292<br />
The Scenic Trust (John McAuley) $81,375 350,000<br />
TOTAL $1,858,443 7,993,302<br />
9,264,742
Directors' Remuneration (Item 6)<br />
The current maximum amount payable to Directors collectively in their capacity as Directors of the<br />
Company in each year is $120,000. This has been the maximum since 2010.<br />
As Directors act in their capacity as Directors on committees, the fees they receive for work thereon<br />
is included in the maximum annual Directors fees set from time to time by the shareholders.<br />
The Directors and their associates are excluded from voting on this resolution pursuant to NZSX<br />
Listing Rule 9.3.1 but may still act as a proxy or voting representative of another person that is not<br />
disqualified from voting under that Listing Rule under Listing Rule 9.3.3 in respect of the shares held<br />
by that other person in accordance with their express instructions.<br />
<strong>NZX</strong> Approval<br />
This notice has been approved by <strong>NZX</strong> Limited.